Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2026)

Camp4 Therapeutics has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $520000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 23.52% year-over-year to $520000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 3.39% YoY) and the FY2025 annual result came in at $1.6 million, down 3.36% from the prior year.
• Depreciation & Amortization (CF) improved to $520000.0 in Q1 2026 per CAMP's latest filing, from $372000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $520000.0 in Q1 2026 and troughed at $372000.0 in Q4 2025.
• A 4-year average of $429000.0 and a median of $422500.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) decreased 11.0% in 2025, then rose 23.52% in 2026.
• Over 4 years, Depreciation & Amortization (CF) stood at $435000.0 in 2023, then slipped by 3.91% to $418000.0 in 2024, then dropped by 11.0% to $372000.0 in 2025, then soared by 39.78% to $520000.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $520000.0, $372000.0, and $416000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.